» Articles » PMID: 19821100

Elevated Vascular Endothelia Growth Factor-A in the Serum and Peritoneal Fluid of Patients with Endometriosis

Overview
Specialty General Medicine
Date 2009 Oct 13
PMID 19821100
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

There has been emergence of evidence suggesting that specific variants of the vascular endothelia growth factor (VEGF) family, based on their ability to regulate angiogenesis, would be pivotal in the pathogenesis of endometriosis. This study was aimed at determining whether high levels of VEGF-A could be found in the serum and peritoneal fluid (PF) of patients with endometriosis. VEGF-A levels were measured by enzyme-linked immunosorbent assay (ELISA) in serum and PF from 46 patients with surgically confirmed endometriosis, and 40 controls with no clinical evidence of the disease or detectable endometriotic lesions at the time of surgical examination. The results showed the mean VEGF-A levels were significantly higher in the serum and PF of patients with endometriosis than in the controls. The VEGF-A levels in the serum and PF of patients with severe endometriosis (stages III-IV) were significantly higher than in those with minimal endometriosis (P<0.001). It was concluded that endometriosis was associated with significant modulation in the levels of circulating VEGF-A.

Citing Articles

The vicious cycle of chronic endometriosis and depression-an immunological and physiological perspective.

Sherwani S, Khan M, Rajendrasozhan S, Al-Motair K, Husain Q, Khan W Front Med (Lausanne). 2024; 11:1425691.

PMID: 39309679 PMC: 11412830. DOI: 10.3389/fmed.2024.1425691.


Down-Regulation of miR-93 Negatively Correlates with Overexpression of VEGFA and MMP3 in Endometriosis: A Cross-Sectional Study.

Muharam R, Febri R, Mutia K, Ameilia Iffanolida P, Maidarti M, Wiweko B Int J Fertil Steril. 2023; 17(1):28-33.

PMID: 36617199 PMC: 9807893. DOI: 10.22074/ijfs.2022.543884.1233.


Nonhormonal therapy for endometriosis: a randomized, placebo-controlled, pilot study of cabergoline versus norethindrone acetate.

DiVasta A, Stamoulis C, Sadler Gallagher J, Laufer M, Anchan R, D Hornstein M F S Rep. 2021; 2(4):454-461.

PMID: 34934987 PMC: 8655411. DOI: 10.1016/j.xfre.2021.07.003.


VASCULAR ENDOTHELIAL GROWTH FACTOR SERUM LEVELS IN WOMEN WITH ADVANCED ENDOMETRIOSIS.

Malutan A, Drugan T, Georgescu C, Ciortea R, Bucuri C, Bobric A Acta Endocrinol (Buchar). 2019; 12(1):7-13.

PMID: 31258793 PMC: 6586760. DOI: 10.4183/aeb.2016.7.


Blood biomarkers for the non-invasive diagnosis of endometriosis.

Nisenblat V, Bossuyt P, Shaikh R, Farquhar C, Jordan V, Scheffers C Cochrane Database Syst Rev. 2016; (5):CD012179.

PMID: 27132058 PMC: 7076288. DOI: 10.1002/14651858.CD012179.


References
1.
Girling J, Rogers P . Recent advances in endometrial angiogenesis research. Angiogenesis. 2005; 8(2):89-99. DOI: 10.1007/s10456-005-9006-9. View

2.
Garcia-Manero M, Alcazar J, Toledo G . Vascular endothelial growth factor (VEGF) and ovarian endometriosis: correlation between VEGF serum levels, VEGF cellular expression, and pelvic pain. Fertil Steril. 2007; 88(2):513-5. DOI: 10.1016/j.fertnstert.2006.11.117. View

3.
Breen E . VEGF in biological control. J Cell Biochem. 2007; 102(6):1358-67. DOI: 10.1002/jcb.21579. View

4.
McLaren J, Prentice A, Charnock-Jones D, Smith S . Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod. 1996; 11(1):220-3. DOI: 10.1093/oxfordjournals.humrep.a019023. View

5.
Donnez J, Smoes P, Gillerot S, Nisolle M . Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod. 1998; 13(6):1686-90. DOI: 10.1093/humrep/13.6.1686. View